We have previously shown that the overall risk of early myocardial infarction was similar between our anti-TNF and nonbiologic DMARD groups, although patients whose RA had responded to the initial anti-TNF agent at 6 months had lower rates of myocardial infarction (11). This evidence concerns the gene TNF and rheumatoid arthritis.